Loading clinical trials...
Loading clinical trials...
The purpose of the study: to increase the efficiency of diagnosis, treatment and prediction of the course of coronary heart disease in patients with adenocarcinoma of the prostate gland, depending on ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dnipropetrovsk State Medical Academy
NCT05109208 · Prostate Adenocarcinoma
NCT06499870 · Prostate Adenocarcinoma
NCT06145035 · Ischemic Heart Disease
NCT07569458 · Ischemic Heart Disease (IHD), Anxiety, and more
NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more
SE Dnipropetrovsk medical academy
Dnipro
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions